| Cancer | Not Cancer | ||
---|---|---|---|---|
 | N | % | N | % |
Cancer status | Â | Â | Â | Â |
 Cancer Tissue | 68 | 100 | 0 | 0 |
 Not Cancer Breast Tissue | 0 | 0 | 89 | 87 |
 Other Tissue | 0 | 0 | 13 | 13 |
 Total (N) | 68 |  | 102 |  |
Gender | Â | Â | Â | Â |
 Male | 4 | 7 | 6 | 8 |
 Female | 54 | 93 | 70 | 92 |
 Total (N) | 58 |  | 76 |  |
Age at diagnosis | Â | Â | Â | Â |
 <40 years | 16 | 30 | 42 | 74 |
 40-49 years | 11 | 21 | 10 | 18 |
 ≥50 years | 26 | 49 | 5 | 9 |
 Total (N) | 53 |  | 57 |  |
HER2 status | Â | Â | Â | Â |
 Positive | 7 | 14 |  |  |
 Negative | 42 | 86 |  |  |
 Total (N) | 49 |  |  |  |
Estrogen receptor status | Â | Â | Â | Â |
 Positive | 29 | 59 |  |  |
 Negative | 20 | 41 |  |  |
 Total (N) | 49 |  |  |  |
Progesterone receptor status | Â | Â | Â | Â |
 Positive | 19 | 40 |  |  |
 Negative | 29 | 60 |  |  |
 Total (N) | 48 |  |  |  |
 Triple negative (ER-, PR-, HER2-) | 16 | 33 |  |  |
 Total (N) | 48 |  |  |  |
Status | Â | Â | Â | Â |
 Died | 11 | 69 |  |  |
 Alive | 5 | 31 |  |  |
 Total (N) | 16 |  |  |  |
Tribe | Â | Â | Â | Â |
 Luyha | 11 | 38 |  |  |
 Kalenjin | 10 | 34 |  |  |
 Kikuyu | 4 | 14 |  |  |
 Luo | 3 | 10 |  |  |
 Teso | 1 | 3 |  |  |
 Total (N) | 29 |  |  |  |
Hormone-based Contraception | Â | Â | Â | Â |
 Single agent (Injected or Pill) | 11 | 50 |  |  |
 Combined (Injected and Pill) | 2 | 9 |  |  |
 Neither | 9 | 41 |  |  |
 Total (N) | 22 |  |  |  |
Marriage | Â | Â | Â | Â |
 Married or widowed | 24 | 92 |  |  |
 Not Married | 2 | 8 |  |  |
 Total (N) | 26 |  |  |  |
Median age (years) | 48.5 years (N = 38) | 31 years old (N = 9) | ||
Mean age (years) | 51.9 years (N = 38) | 35.6 years (N = 9) |